Stanbridge E J
Ludwig Institute for Cancer Research, Melbourne Tumour Biology Branch, Royal Melbourne Hospital, Victoria, Australia.
Cancer Surv. 1992;12:5-24.
There is now ample genetic and some functional evidence for the existence of tumour suppressor genes. Although much of the functional evidence has been derived from somatic cell hybrid and chromosome transfer studies, it is critical that cloned candidate tumour suppressor genes be used in such functional assays. Our experience with RB and p53 indicates that much will be learned about the control of the cell cycle from studies of tumour suppressor genes. However, the handful of candidate genes cloned to date also indicates a variety of cellular localizations and cellular functions. Thus, just as oncogenes seem to act to promote growth at many levels of metabolic control, it would seem that tumour suppressor genes act in complementary ways to control cell proliferation. The molecular genetic study of cancer has truly entered an exciting phase.
目前,已有大量遗传学证据以及一些功能学证据证明肿瘤抑制基因的存在。尽管许多功能学证据来自体细胞杂交和染色体转移研究,但在这类功能分析中使用克隆的候选肿瘤抑制基因至关重要。我们对RB和p53的研究经验表明,从肿瘤抑制基因的研究中将能了解到很多关于细胞周期调控的知识。然而,迄今为止克隆出的少数候选基因也表明了其在细胞定位和细胞功能方面具有多样性。因此,正如癌基因似乎在代谢控制的多个层面发挥促进生长的作用一样,肿瘤抑制基因似乎以互补的方式控制细胞增殖。癌症的分子遗传学研究确实已进入一个令人兴奋的阶段。